Original Research
Accepted on 26 Aug 2024
A single intraarticular injection of a tranexamic acid-modified hyaluronic acid (HA/TXA) alleviates pain and reduces OA development in a murine model of monosodium iodoacetate-induced osteoarthritis
in Integrative and Regenerative Pharmacology